Refine
Year of publication
Has Fulltext
- yes (23)
Is part of the Bibliography
- no (23)
Keywords
- Healthy adults (2)
- 3′UTR length (1)
- APA (1)
- Acute coronary syndrome (1)
- Adoption (1)
- Angioplasty (1)
- Atrial fibrillation (1)
- B-cell lymphoma (1)
- Beauveria brongniartii (1)
- Biomarkers (1)
- Blocked occlusion (1)
- Body sway (1)
- Brain metastasis (1)
- Breast cancer (1)
- CFIm (1)
- Cancer treatment (1)
- Cardiac troponin (1)
- Clinical Trials and Observations (1)
- Clinical competence (1)
- Clinical trial (1)
- Coleoptera (1)
- Complementary mobility services (1)
- CyberKnife (1)
- Diagnostic medicine (1)
- Discrete choice experiment (1)
- Dual response (1)
- Electric vehicles (1)
- Engerlinge (1)
- Entomopathogene Pilze (1)
- Extreme hypo-fractionation (1)
- FIP1 (1)
- Flexible Endoscopic Evaluation of Swallowing (1)
- Hemodynamics (1)
- Lesions (1)
- Localized prostate cancer (1)
- Lymphoid Neoplasia (1)
- MACE-seq (1)
- Meersseman test (1)
- Metarhizium anisopliae (1)
- Muscular diseases (1)
- Myocardial infarction (1)
- Nanoscale materials (1)
- Natriuretic peptide (1)
- Necrosis (1)
- Nervous system diseases (1)
- Non-small cell lung cancer (1)
- Pulmonary embolism (1)
- Pulmonary hypertension (1)
- Robotic Radiosurgery (1)
- SRSF3 (1)
- SRSF7 (1)
- Sample-based longitudinal study (1)
- Scarabaeidae (1)
- Stereotactic body radiation therapy (1)
- Stereotactic radiosurgery (1)
- Stroke (1)
- Symmetrical blocked occlusion (1)
- Toxicity (1)
- Troponin (1)
- USP9X (1)
- Upper body posture (1)
- Videorasterstereography (1)
- Weight distribution (1)
- XIAP (1)
- antibodies (1)
- b-cell lymphomas (1)
- bendamustine (1)
- body sway (1)
- body weight distribution (1)
- cancer (1)
- chemotherapy regimen (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- dPAS (1)
- ectosomes (1)
- entomopathogenic fungi (1)
- exosomes (1)
- extracellular vesicles (1)
- female subjects (1)
- grub (1)
- guidelines (1)
- hematopoietic stem cell transplantation (1)
- iCLIP (1)
- leukapheresis (1)
- lymphoma (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mitosis (1)
- pPAS (1)
- pancreatic cancer (1)
- reproducibility (1)
- rigor (1)
- rituximab (1)
- standard value (1)
- standardization (1)
- ubiquitin (1)
Institute
- Medizin (14)
- Biochemie, Chemie und Pharmazie (2)
- Biowissenschaften (2)
- Physik (2)
- Biochemie und Chemie (1)
- Georg-Speyer-Haus (1)
- Wirtschaftswissenschaften (1)
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points.
The current pandemic situation caused by the Betacoronavirus SARS-CoV-2 (SCoV2) highlights the need for coordinated research to combat COVID-19. A particularly important aspect is the development of medication. In addition to viral proteins, structured RNA elements represent a potent alternative as drug targets. The search for drugs that target RNA requires their high-resolution structural characterization. Using nuclear magnetic resonance (NMR) spectroscopy, a worldwide consortium of NMR researchers aims to characterize potential RNA drug targets of SCoV2. Here, we report the characterization of 15 conserved RNA elements located at the 5′ end, the ribosomal frameshift segment and the 3′-untranslated region (3′-UTR) of the SCoV2 genome, their large-scale production and NMR-based secondary structure determination. The NMR data are corroborated with secondary structure probing by DMS footprinting experiments. The close agreement of NMR secondary structure determination of isolated RNA elements with DMS footprinting and NMR performed on larger RNA regions shows that the secondary structure elements fold independently. The NMR data reported here provide the basis for NMR investigations of RNA function, RNA interactions with viral and host proteins and screening campaigns to identify potential RNA binders for pharmaceutical intervention.